Arrowgrass Capital Partners (US)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-143,941
Closed -$6.79M 114
2019
Q3
$6.79M Buy
143,941
+53,279
+59% +$2.54M 0.5% 55
2019
Q2
$4.5M Sell
90,662
-62,010
-41% -$2.91M 0.11% 203
2019
Q1
$6.5M Buy
152,672
+44,619
+41% +$1.97M 0.19% 151
2018
Q4
$4.44M Buy
+108,053
New +$4.64M 0.16% 150
2018
Q3
Sell
-30,770
Closed -$1.41M 226
2018
Q2
$1.34M Buy
+30,770
New +$1.43M 0.05% 172
2018
Q1
Sell
-58,072
Closed -$2.94M 346
2017
Q4
$2.94M Buy
58,072
+10,822
+23% +$570K 0.03% 355
2017
Q3
$2.46M Sell
47,250
-200,678
-81% -$9.77M 0.02% 434
2017
Q2
$12.1M Buy
247,928
+60,912
+33% +$2.83M 0.09% 268
2017
Q1
$8.8M Sell
187,016
-4,131
-2% -$197K 0.09% 260
2016
Q4
$9.18M Sell
191,147
-27,090
-12% -$1.24M 0.1% 193
2016
Q3
$8.64M Buy
218,237
+42,498
+24% +$1.6M 0.12% 150
2016
Q2
$6.24M Buy
175,739
+57,338
+48% +$2.24M 0.07% 170
2016
Q1
$4.64M Buy
118,401
+45,759
+63% +$1.71M 0.06% 196
2015
Q4
$3.12M Sell
72,642
-2,227
-3% -$97.9K 0.04% 200
2015
Q3
$3.15M Buy
+74,869
New +$3.5M 0.06% 202

Other funds holding MET

Arrowgrass Capital Partners (US)'s MET Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) sold out of MetLife (MET) in Q4 2019, closing a stake of 143,941 shares — an estimated $6.79M sold.

Arrowgrass Capital Partners (US) first reported a position in MET in Q3 2015 and held it in 15 quarters. The position peaked at $12.1M in Q2 2017. 1,114 funds tracked by Wall St. Rank hold MET as of Q4 2019.

  • Arrowgrass Capital Partners (US) reported no remaining MetLife position as of Q4 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 143,941 MetLife shares in Q4 2019, an estimated $6.79M.
  • Arrowgrass Capital Partners (US) first reported a position in MetLife in Q3 2015 and held it in 15 quarters.
  • Arrowgrass Capital Partners (US)'s MetLife position peaked at $12.1M in Q2 2017.
  • 1,114 funds tracked by Wall St. Rank held MetLife as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.